Početna › Ewingov sarkom › Pennsylvania
Kliničke studije za Ewingov sarkom u državi Pennsylvania
10 studija za Ewingov sarkom traži sudionike na lokacijama u državi Pennsylvania.
Gradovi u državi Pennsylvania
Službeni tekst studije (engleski)
Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
- Childrens Hospital of Philadelphia, Philadelphia
U tijeku regrutacijaFaza 1
Od 2 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07297979Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
U tijeku regrutacijaFaza 1/2
6 Months – 25 Years · Oba spola · Ažurirano 17. ruj 2026. · NCT06395103Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Children's Hospital of Philadelphia- Center for Childhood Cancer Research, Philadelphia
- University of Pennsylvania Abramson Cancer Center, Philadelphia
U tijeku regrutacijaFaza 1
Od 12 do 85 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT03715933Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
- Children's Hospital of Philadelphia, Philadelphia
- University of Pennsylvania, Philadelphia
U tijeku regrutacijaFaza 1
Od 5 do 40 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06156410Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
U tijeku regrutacijaFaza 1/2
Do 26 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06465199Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
U tijeku regrutacijaFaza 1/2
Do 30 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06541262Lurbinectedin in FET-Fused Tumors
- Children's Hospital of Philadelphia, Philadelphia
U tijeku regrutacijaFaza 1/2
Od 10 godina i više · Oba spola · Ažurirano 2. ruj 2026. · NCT05918640Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital of Philadelphia, Philadelphia
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
U tijeku regrutacijaFaza 1/2
12 Months – 30 Years · Oba spola · Ažurirano 25. kol 2026. · NCT04851119Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
U tijeku regrutacijaFaza 2
Od 0 do 50 godina · Oba spola · Ažurirano 9. srp 2026. · NCT07321912Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Children's Hospital of Philadelphia, Philadelphia
U tijeku regrutacijaFaza 1/2
Od 2 do 30 godina · Oba spola · Ažurirano 3. velj 2026. · NCT05734066Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.